BRIEF published on 09/24/2026 at 18:05, 28 days 17 hours ago Inoviem Scientific and DeepLife: Innovative Collaboration for IBD Artificial Intelligence Inoviem Scientific IBD DeepLife Validation On Human Tissue
BRIEF published on 08/24/2026 at 18:05, 1 month 29 days ago Aton completes the repayment of its ORAs subscribed with Iris Capital Strategic Development Funding Aton IRIS Capital ORA Reimbursement
BRIEF published on 06/25/2026 at 18:20, 3 months 27 days ago Pims Technology: Towards Optimizing Cancer Treatments Oncology Personalized Medicine PIMS Technology European Presence Therapeutic Evaluation
BRIEF published on 05/07/2026 at 10:05, 5 months 16 days ago Aton Group is organizing a webinar for shareholders and investors on May 12, 2026 Shareholders Biotechnology Webinar 2025 Results Aton Group
BRIEF published on 04/28/2026 at 18:05, 5 months 24 days ago 2025 Annual Results: Aton Group Strategic Partnerships Biotechnology Business Expansion 2025 Results Aton Group
BRIEF published on 04/23/2026 at 18:05, 5 months 29 days ago B Cell Design innovates in response to the shortage of diagnostic reagents Patented Technology In Vitro Diagnostics Monoclonal Antibodies B Cell Design Aton Group
BRIEF published on 04/01/2026 at 18:05, 6 months 21 days ago Aton Group: Towards a Reduction of Clinical Failures in Pharmaceuticals Clinical Trials Pharmaceutical R&D Aton Group Predictability
BRIEF published on 03/11/2026 at 18:35, 7 months 11 days ago Inoviem Scientific Advances Drug Development with Patient-Centric Approach Personalized Medicine Pharmaceutical Innovation Inoviem Scientific Patient-centric Drug Development Preclinical Programs
PRESS RELEASE published on 03/11/2026 at 18:30, 7 months 11 days ago ATON: UPDATE ON THE ACTIVITIES OF ITS SUBSIDIARY INOVIEM SCIENTIFIC Aton Group's subsidiary, Inoviem Scientific, transforms drug development by prioritizing patient samples & AI technology, accelerating preclinical programs with high-value translational data AI Technology Drug Development Inoviem Scientific Aton Group Patient Sample
BRIEF published on 03/11/2026 at 18:20, 7 months 11 days ago Inoviem Scientific: Advances in Pharmaceutical Development Personalized Medicine Pharmaceutical Development Translational Pharmacology Inoviem Scientific Integrated Platform
Published on 10/23/2026 at 02:20, 8 hours 52 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 11 hours 42 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 12 hours 42 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 19 hours 12 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 20 hours 42 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 11:00, 12 minutes ago Annual General Meeting Approves Contribution: Innok Robotics on Course for the Public Capital Market
Published on 10/23/2026 at 10:18, 53 minutes ago Schirp Schjmidt-Morsbach Rechtsanwälte PartG: Investor Lawsuits in the Wirecard Case: Federal Court of Justice Dismisses EY from Model Proceedings The lead plaintiff’s attorneys welcome the decision
Published on 10/23/2026 at 10:05, 1 hour 7 minutes ago SINEXCEL Achieves IEC 62443-4-1 Certification for Cybersecurity Compliance
Published on 10/23/2026 at 09:00, 2 hours 12 minutes ago Municipality Finance issues a USD 135 million tap under its MTN programme
Published on 10/22/2026 at 18:00, 17 hours 12 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 17 hours 12 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 17 hours 12 minutes ago H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 17 hours 25 minutes ago Aéroports de Paris SA - 2026 9-month revenue
